title: Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?".
authors.affiliation: Gastroenterology Unit, Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: ester.vanni@unito.it.
authors.forename: Ester
authors.initials: E
authors.lastname: Vanni
authors.affiliation: Gastroenterology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Bugianesi
authors.affiliation: Gastroenterology Unit, Department of Oncology, University of Turin, Turin, Italy.
authors.forename: Giorgio Maria
authors.initials: GM
authors.lastname: Saracco
mesh_terms: D000998:Antiviral Agents; D003920:Diabetes Mellitus; D019698:Hepatitis C, Chronic; D006801:Humans; D012254:Ribavirin
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin